Structural insight into substrate binding of Acinetobacter baumannii polyphosphate-AMP phosphotransferase (PPK2), a

Lalit Kumar Gautam1, Prince Sharma2, Neena Capalash1

  • 1Department of Biotechnology, Panjab University, BMS Block-I, Sector- 25, Chandigarh, 160014, India.

Insights

Acinetobacter baumannii infections are a growing threat due to antibiotic resistance. This study explores polyphosphate kinase 2 (PPK2) as a potential drug target by analyzing its substrate binding. Identifying key interactions could lead to new treatments.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Acinetobacter baumannii is a significant opportunistic pathogen causing severe infections.
  • Rising carbapenem resistance in A. baumannii necessitates novel therapeutic targets.
  • Polyphosphate kinase 2 (PPK2) is a known pathogenicity factor but unexplored in A. baumannii.

Purpose of the Study:

  • To investigate the substrate binding of Acinetobacter baumannii polyphosphate kinase 2 (AbPPK2).
  • To explore AbPPK2 as a potential drug target for combating A. baumannii infections.

Main Methods:

  • Development and validation of a homology model for AbPPK2.
  • Molecular docking simulations of ATP and ADP within the AbPPK2 binding pocket.
  • Analysis of catalytic cleft residues involved in substrate interaction.

Main Results:

  • A homology model of AbPPK2 was successfully created and validated.
  • Molecular docking identified binding interactions for ATP and ADP.
  • Common residues interacting with both ATP and ADP in the catalytic cleft were determined.

Conclusions:

  • AbPPK2 is a promising drug target for A. baumannii.
  • The identified common residues are crucial for designing AbPPK2 inhibitors.
  • This research provides a foundation for developing novel anti-Acinetobacter therapies.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.8K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K